With over 25 years of experience, LifeArc specializes in advancing early-stage scientific ideas to develop diagnostics, treatments, and cures. Their work has resulted in four licensed medicines, including Keytruda for cancer and Actemra for rheumatoid arthritis. They have also developed a diagnostic for antibiotic resistance and a test for antimicrobial resistance. LifeArc is committed to improving patient outcomes and operates in the fields of biotechnology, healthcare, and medical research.